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ABSTRACT
YUJING ZHANG: Intravenous Solution Wastage in Hospital Pharmacy at Baptist
Memorial Hospital-North Mississippi (Oxford)
(Under the direction of Erin Holmes)

Introduction: IV solution wastage refers to IV medications made for a patient that
remain unused by that patient for a variety of reasons, and have subsequently expired,
or for other reasons cannot be used for another patient (recycled), and therefore must
be disposed of. This problem is widespread across hospital pharmacies in the U.S.
and the world. BMH-NM (Oxford) pharmacy utilizes many waste reduction strategies
but has never monitored its IV solution wastage. Therefore, the objective of this study
was to identify the number of IV solutions wasted in a month and the subsequent
financial loss in terms of drug cost, and categorize the wastage by drug name and
drug class. Methods: This study was conducted using a cross-sectional, observational,
prospective study design to quantify the amount of IV solution wastage that occurred
at BMH-NM (Oxford). For 30 days in March, 2017, the researcher collected data
from wasted IV solutions set aside by pharmacy technicians and calculated the drug
cost. For each wastage indicator (number of bags and drug cost), the top 10 drugs and
drug classes were ranked, and descriptive statistics were conducted to further
visualize the impact. Results: From March 1, 2017, to March 30, 2017, the BMHNM (Oxford) pharmacy wasted 285 bags of IV solution, resulting in a financial loss
of $4025.66 in drug cost. There were 46 different types of drugs from 28 different
drug classes. Conclusion: The financial loss from a single month of IV solution
v

wastage was significant for a 217-bed rural hospital. A variety of drugs and drug
classes were identified as targets for waste reduction. Potential causes for wastage
were drug-specific, and both volume and cost of waste need to be considered for
reducing overall IV solution wastage.
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BACKGROUND
Description of the Problem
In hospital pharmacies across the country, and even the world, pharmacists and
technicians experience the frustration of intravenous (IV) solution wastage. This wastage
refers to IV medications made for a patient that remain unused by that patient for a
variety of reasons, and have subsequently expired, or for other reasons cannot be used for
another patient (recycled), and therefore must be disposed of.
There can be several negative consequences that result from wasted IV solutions.
On the anecdotal side, IV solution wastage could lead to reduced work satisfaction and
reduced productivity in the pharmacy. It takes time and resources for technicians and
pharmacists to verify the order, prepare the solution, double-check the bag, and send it to
the appropriate location. Seeing IV bags go to waste and realizing that all the work was
done in vain can sometimes be frustrating and discouraging to the pharmacy staff. In
addition, they could have used that time verifying other orders or preparing other
medication, resulting in opportunity costs for labor.
On the quantitative side, the financial cost of IV solution wastage can be a
significant burden on a hospital pharmacy’s budget. Uchida et al. (1994) conducted a
year-long study at the 493-bed University of California, Irvine Medical Center in 1991
and found 14,035 wasted IV solutions totaling an estimated $86,000 in drug costs, or 2.5%
of the total IV drug cost, in a 12-month period. Accounting for inflation, the loss equates
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to about $150,000 in today's value. Of course, other factors over the past 25 years, such
as healthcare reform and rising drug costs, may realistically result in a much higher
wastage cost.

Literature Evaluation of IV Solution Wastage
Because IV solution wastage is a serious and widespread problem in hospital
pharmacies, many researchers around the world have looked into the magnitude of waste
in their local hospitals. In an 800-bed teaching hospital in Saudi Arabia, for example, AlDhawailie (2011) collected 265 unused intravenous medication in a single month in 2009.
A year earlier at a large teaching hospital in Cincinnati, OH, Chiu (2009) found that an
average of 2,173 IV bags was wasted per month during a 3-month study period, costing
the pharmacy on average $47,977 each month and an estimated $575,000 per year. A
dated, but more comprehensive study, conducted by Birdwell et al. (1993) showed that
among 237 surveyed U.S. hospitals, the mean IV solution wastage rate was 2.83%—
meaning for every 100 bags made, 3 were wasted. Most alarming is that despite hospital
pharmacies being aware of the issue of IV solution wastage, only a minority of those
pharmacies regularly monitor for IV wastage. In the same survey by Birdwell, only 35.9%
of the respondents indicated that waste is monitored and recorded on a daily basis. Over
40% said that they either only monitored waste occasionally or never monitor it at all.

Causes of IV Solution Wastage
Quantifying IV wastage is important, but it is also important to understand the
causes of wasted IV solutions. Just like everything else in health care, the reasons are
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complicated. Most often, IV bags are wasted because they have short expiration dates,
and by the time technicians bring them back to the pharmacy, they can no longer be
recycled. There are several reasons why IV bags are returned to the pharmacy. Usually it
is because the doctor discontinued or changed the order, and the solution has already
been mixed and sent up to the floor. Other times nurses do not transfer the medication
with the patient to a different unit, causing the bag to expire in a medication bin on the
patient’s old floor. Lastly, if a patient passed away before the medication was due, but
after it was made, the nurse has no choice but to return the bag to pharmacy. Uchida
(1994) observed in her article, "most of these problems can be attributed to poor
communication between physicians, nurses, and pharmacists."

Methods to Reduce IV Solution Wastage
From my personal experience working for three years as a hospital pharmacy
technician, potential IV solution wastage is inevitable, but many times it is avoidable.
There are many measures to reduce waste. Birdwell et al. (1993) focused on four areas.
First, he found that the lowest wastage rate occurred when there is computerized
notification (versus written or verbal notification) to discontinue IV administration.
Specifically, "as the elapsed time from the discontinuation of an IV drug or solution to
notification in the pharmacy increased from <1 hour to >4 hours, the actual and perceived
mean wastage rates also increased." Second, he found that the active retrieval of IV
solution from wards or from designated location reduced wastage rate. Third, 85.9% of
the surveyed hospitals recycled IV bags until their expiration date, and compared to more
conservative recycling policies, this policy had the lowest wastage rates. Lastly, the
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highest wastage rates came from hospitals that used manufacturer stability data in
determining the expiration dating policy, while the lowest rates came from the handful of
hospitals who used sterility instead of stability data. Again, Birdwell's survey was
conducted in 1990 when computerized physician order entry (CPOE) system was not yet
widespread, so today there are many other methods, such as barcode scanning technology,
that could be used to reduce intravenous solution wastage.

Baptist Memorial Hospital-North Mississippi (Oxford) Pharmacy Efforts to Reduce
Wastage
The pharmacy at Baptist Memorial Hospital-North Mississippi (BMH-NM) in
Oxford, a 217-bed large rural hospital, already incorporates many of these best practices
to reduce waste. When physicians order certain IV solutions (e.g., those with short
stability periods or those that are made with expensive drugs) using a CPOE system,
pharmacists process the order as usual. However, technicians pin the label on a board
outside the IV room rather than immediately making the IV after the order is placed. An
hour before the medication is due, the technician checks to see if the order has been
discontinued or if the patient has been transferred. If the order is still active, and the
patient location is updated, then the technician will make the bag, and the medication will
be either sent by pneumatic tube or hand-delivered to the nursing unit.
There are several other mechanisms that the pharmacy at BMH-NM (Oxford) has
in place to minimize IV wastage. When technicians are on nursing floors on routine
medication deliveries, they will actively retrieve unused IV bags that were due at least 6
hours ago, and once the technician gets back to the pharmacy, they will credit the bags
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back to the patients (meaning, to ultimately remove this IV from the patient’s hospital
bill). If not expired, these IVs will be stored for the purpose of reuse for other patients as
appropriate (see batch fill process section, below).
In other instances, when the IV technician makes extra bags for frequently used
solutions, he or she will put the new bags behind the old ones in the overstock bin so the
ones expiring first will get used first. Also, to avoid IV bags from going missing on
nursing units, the technicians try to hand deliver as many IV bags as possible to the
medication room on the nursing unit instead of sending them by pneumatic tube to the
nursing unit. If a nurse calls the pharmacy for replacements of missing IV bags because a
patient has recently transferred from a different floor, the tech will call the nurse from the
patient's previous floor to try to find the bag before making a new one. Finally, for IV
bags with short stability, the hospital pharmacy purchases premixed bag with longer
expiration dates.

Batch Fill Process of IV Solutions at BMH-NM (Oxford)
To fully understand how IV wastage is managed at BMH-NM (Oxford), it is
important to understand the daily process of filling IV orders for patients. Every morning
at 7:00 am, labels are printed for IVs due between noon and 6:00 pm that day. The IVs
are made and delivered at 9:30 am. The timeline for the second, third, and fourth batches
of IVs for the day are outlined in Table 1 below.
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Table 1. IV Batch Fill Process at BMH-NM Pharmacy.
7:00 AM
9:30 AM
11:00 AM
2:00 PM
3:00 PM
4:00 PM
6:00 PM
7:30 PM

First batch prints for IVs due noon to 6 PM today
Rounder delivers first batch
Second batch prints for IVs due 6 PM to midnight today
Rounder delivers second batch
Third batch prints for IVs due midnight to 6 AM tomorrow
Rounder delivers third batch
Fourth batch prints for IVs due 6 AM to noon tomorrow
Rounder delivers fourth batch

In addition to the scheduled IV batches illustrated above, labels for new orders,
STAT doses (immediate does for patients), and PRN (as needed) doses print out
sporadically throughout the day. The IV technician usually makes these bags as soon as
the labels print out, and the mixed solutions are tubed to the floor, unless it contains drugs
that cannot be shaken or are narcotics, in which case the bags will be hand-delivered to
the nurse.

Recycling and Wasting Policy at BMH-NM (Oxford)
BMH-NM (Oxford) has established a process for collecting discontinued IV bags.
Every time an IV order gets discontinued, a D/C (shorthand for “Discontinue”) label
prints out. If the label prints out before the rounding technician delivers, then a technician
would first try to find the original label and credit it before a bag is even made, or if the
bag is already made, find the bag, credit it, and save it for use for another patients
(recycling). If the D/C label prints out after the rounder has left the pharmacy for delivery,
then the next rounding technician will bring the discontinued bag back and credit it. The
IV bag will be stored for use for another patient if appropriate. If the solution has already
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expired and cannot be recycled for another use, then the bag will be cut up in the sink as a
means of destruction.
In addition to making IV solutions for specific patients, the pharmacy also
prepares commonly used IV bags in bulk to be stored in the pharmacy and in different
hospital units, which can be another source of IV solution wastage. As mentioned in the
previous section, technicians often make extra IV bags for frequently used drugs, and
occasionally the extra bags expire before they can be used. In nursing units, BMH-NM
(Oxford) installed Omnicell Automated Dispensing Cabinets in 2015 to store unit-dose
medication, premixed fluids, and frequently prescribed IV solutions with a 15-day or 30day stability period at room temperature. These medication cabinets allow nurses to
retrieve medication for their patients instantly instead of waiting on pharmacy technicians
to deliver or tube the medication. Every day, an item expiration tracking report prints out,
detailing every item in every Omnicell cabinet that will expire in the next 30 days. In this
way, technicians keep track of which IV solutions are expiring in which Omnicell cabinet,
and every weekend the rounding technicians bring back bags that expire in the following
week to be cut up in the sink.

Study Significance
Conducting a study to monitoring IV solution wastage at BMH-NM (Oxford) is
important for several reasons. First, there has been little recent research on IV solution
wastage in the United States, especially in rural hospitals. It will be interesting to see how
findings at BMH-NM (Oxford) compare with numbers from previous studies and at large
teaching hospitals. Second, this hospital pharmacy has never monitored its drug wastage,
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even though inefficiencies arising from IV wastage have been noted. Lastly, this research
can have important financial and policy implications for the pharmacy. Anecdotally,
BMH-NM (Oxford) has often been referred to as the "cash cow" for the Baptist
healthcare corporation. Quantifying IV solution waste and subsequent financial costs has
the potential to create real policy changes within the pharmacy and the hospital at large.

Study Objectives
The overall purpose of this study is to monitor and quantify IV solution wastage
at the pharmacy at BMH-NM (Oxford). The specific objectives of this study are:
1. To identify the number of IV solutions wasted at BMH-NM (Oxford) in a month
and to categorize the solutions by drug name and drug class.
2. To quantify the financial loss in terms of drug cost to BMH-NM (Oxford) as a
result of wasted IVs at BMH-NM (Oxford) pharmacy and categorize the loss by
drug name and drug class.
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METHODS
Study Design
This study was conducted using a cross-sectional, observational, prospective
study design to quantify the amount of IV solution wastage that occurred at BMH-NM
(Oxford). The study was approved by the Baptist Memorial Healthcare Corporation IRB
as well as the University of Mississippi IRB.

Data Collection
In February 2017, the researcher prepared the pharmacy staff at BMH-NM
(Oxford) for the data collection by holding a staff meeting with the pharmacy technicians
and sending an email to technicians and pharmacists about the study. Technicians were
given detailed instructions pertaining to the collection process in the meeting as well as in
the email, and pharmacists were given a broad overview of the study purpose and method
in the email so that they were aware of the ongoing data collection. The data collection
process was piloted prior to the start of the study to assure adherence to, and
understanding of, procedures.
There are three general sources of wasted IV solutions: unused bags from nursing
units, expired pre-made bags in Omnicell machines, and expired bags in refrigerator
overstock bins in the pharmacy. Technicians were given separate instructions for each
source.
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For bags returned from daily rounding and retrieved from nursing units
(see Figure 1), technicians were told to sort out the wasted IV solutions,
leave the medication labels intact, and place the wasted IV bags in one of
the designated collection bins in the pharmacy. They were instructed not
to credit the bags back to the patients to avoid the reflex of tearing off the
label immediately after crediting. To assure them that the bags would still
be credited, they were told that the researcher would credit the bags once
she finishes data collection for the day.



For expired pre-made bags returned from Omnicell machines, technicians
were instructed to simply place them in the collection bins. These bags
would be identified as Omnicell expires because they lack medication
labels.



For bags that expired in the pharmacy refrigerator, technicians were
similarly instructed to place them in the collection bins instead of cutting
them up in the sink. These bags would be identified as overstock expires
because they would have incomplete medication labels that lack the
section with patient-identifying information.

If technicians accidentally tore off medication labels or cut up the bags in the sink,
they were told to put the unlabeled or empty bags in the collection bins regardless so that
the researcher can get an accurate count of the number of IV bags wasted.
The physical preparation for data collection included hanging up signs in
conspicuous areas of the pharmacy to remind technicians on the data collection process
and setting up two collection bins in the pharmacy. Three signs were hung: one above the
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computer at the technician island, one below the monitor of the computer used for
crediting medications, and one above the sink in the IV room. These locations were
chosen because they are visible to technicians and are key sites where wasted IV bags are
normally processed. Two labeled collection bins were set up: one next to the crediting
computer, and one near the sink in the clean room.
Data collection began on March 1st, 2017, and ended on March 30, 2017. Each
day at 8 pm, the researcher went to the pharmacy to check the collection bins, enter data
onto an encrypted data collection Excel spreadsheet, credit appropriate bags back to the
patients, and properly dispose of the wasted IV solutions by tearing off and shredding the
medication labels and cutting the bags up in the sink.
The encrypted data collection Excel spreadsheet, henceforth referred to as the
daily log, is a table with descriptions of each wasted bag in rows (see Table 2 below).
The descriptors included bag number, hospital unit, drug name, dose strength, and order
type. Each bag was coded using a 6-digit code: the first three numbers indicated the date
of collection, and the last three numbers differentiated bags wasted on the same day. The
hospital unit was the unit on the medication label, not necessarily where the technician
retrieved the bag. For example, bags expired in the fridge might be a recycled bag
returned from a nursing unit, but because the patient-identifying section of the medication
label, which contains the unit number, has been removed, the bag is only identifiable as
fridge overstock. The drug name and dose strength were either identified from the
medication label or, in the case of the pre-made bags expired in Omnicell machines, from
the attached vials. The order type indicated whether the bag was made as a first dose
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(FD), a PRN (as needed) dose, a scheduled dose that was printed in the IV batch (CF), or
a redispensed dose to replace a missing dose.
Table 2. Sample Daily Log
Date:
3/1/2017

Bag #

Unit

Drug

Dose

301001

2nd

40mEq/20ml

301002
301003
301004

SD
ER
Omnicell

Potassium
Chloride
Ibuprofen
Thiamine
meropenem

Order
Type
CF

400mg
100mg
500mg

CF
FD
restock

At the end of the 30-day collection period, the researcher provided the pharmacy
buyer with a list of drug products with specific brand/drug name, concentration, and vial
sizes used to make each of the wasted IV solutions from the daily log. The specific
products were determined based on the standardized process of sterile compounding at
the BMH-NM (Oxford) pharmacy, which is knowledge that I acquired from working as a
technician at this pharmacy for three years. For example, three different types of
vancomycin vials are used to prepare three different dosage strengths: a 750mg AddVantage vial for the 750mg dose, a 1g Add-Vantage vial for the 1g dose, and a 5g bulk
vial for any doses above 1g. The buyer then provided the cost of each item in unit price
($/vial) format in a report generated from the wholesaler website.

Data Analysis
A list of all of the drugs wasted was compiled by alphabetizing the "Drug"
column in the daily log. Then the number of bags wasted was summed for each dosage
strength of each drug.
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Next, the drug cost of each bag was calculated by determining the unit dose
multiplier (i.e. the number of vials used) for each bag. Using the standardized process for
sterile compounding as a guide, the researcher normalized the different dose strengths of
each drug to a unit price multiplier (see Figure 1). By multiplying the unit price multiplier
with the unit price of each product, the drug cost of each wasted IV solution was
calculated.
Next, the total number of bags for each drug was calculated by summing the
number of bags for each dosage strength. Similarly, the total drug cost was calculated for
each drug.
To calculate wastage by drug class, the pharmacological class of each drug was
determined using Lexi-Comp. Then the drugs were grouped into various classes. Within
each class, each drug's wastage was summed to calculate wastage by number of bags and
by drug cost per drug class.
For each of the four wastage indicators (number of bags wasted by drug, number
of bags wasted by drug class, drug cost by drug, and drug cost by drug class), the
numerical value was sorted from highest to lowest to reflect the impact on IV wastage by
each drug or drug class. Descriptive statistics was conducted to further visualize the
impacts.
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If the dose strength is the same as the total amount in the
vial (i.e. the entire content of the vial was used to make the
bag), the unit price multiplier is 1

If the dose strength is more than the total amount in one vial
(e.g. 10 ml of drug is in the bag and the vial size is 5 ml), divide
the dose strength by the amount in one vial and round the
number up to the nearest whole number

Single Dose
If the dose strength is exactly half of the total amount in one
vial (e.g. 4 ml of drug is in the bag and the vial holds 8 ml),
sum the total number of bags with this dose strength and
divide by 2, round up to the nearest whole number

Does this
drug come
in single
dose or
multidose
vials?

Any other dose strength less than the total
amount in one vial has a unit price multiplier
of 1

Multidose

sum all dose strength in terms of volume (ml)
and divide by the volume in one vial, rounding
up to the nearest whole number

Figure 1. Unit Price Multiplier Calculation
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RESULTS
From March 1, 2017, to March 30, 2017, the BMH-NM (Oxford) pharmacy
wasted 285 bags of IV solution, resulting in a financial loss of $4025.66 in drug cost.
There were 46 different types of drugs from 28 different drug classes. Table 3 gives a
summary of the total IV solution wastage for each drug as well as an index for the drug
class that each drug is in.
The top ten drugs wasted by number of bags included potassium chloride,
meropenem, penicillin G potassium, cefazolin, ibuprofen, thiamine, vancomycin, folic
acid, phenylephrine, and multivitamin infuvite (Table 4). These drugs represented 68% of
the total waste by number of bags (Figure 2).
The top ten drug classes wasted by number of bags included electrolytes, vitamins,
penicillin antibiotics, carbapenem antibiotics, cephalosporin antibiotics, NSAIDs,
glycopeptide antibiotic, alpha-adrenergic agonist, aminoglycoside antibiotics, and
anticonvulsant (Table 5). These drug classes represented 83% of the total waste by
number of bags (Figure 3).
The top ten drugs wasted by drug cost included vasopressin, daptomycin,
ceftaroline fosamil, nitroprusside, meropenem, norepinephrine, aztreonam, anidulafungin,
sodium bicarbonate, and phenylephrine (Table 6). These drugs represented 71% of the
total loss in drug cost (Figure 4).
The top ten drug classes wasted by drug cost included hormone analog
antidiuretic, cephalosporin antibiotics, cyclic lipopeptide antibiotic, electrolytes,
15

vasodilator antihypertensive, antifungal, carbapenem antibiotics, alpha-/beta- agonist,
monobactam antibiotics, and vitamins (Table 7). These drug classes represented 79% of
the total loss in drug cost (Figure 5).
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Table 3. Total IV Solution Wastage in a 30-Day Period
Drug Class

Drug Name

alpha-/beta- agonist
alpha-adrenergic agonist
Analgesic
antianginal
antibiotic, aminoglycoside
antibiotic, aminoglycoside
antibiotic, carbapenem
antibiotic, cephalosporin
antibiotic, cephalosporin
antibiotic, cephalosporin
antibiotic, cephalosporin
antibiotic, cyclic
lipopeptide
antibiotic, glycopeptide
antibiotic, macrolide
antibiotic, miscellaneous
antibiotic, monobactam
antibiotic, penicillin
antibiotic, penicillin
antibiotic, penicillin
antibiotic, penicillin
anticonvulsant
anticonvulsant
antidiarrheal
antidiuretic hormone analog
antiemetic
antifungal
antifungal
antihypertensive, diuretic
antihypertensive, diuretic
antihypertensive, diuretic
antihypertensive,
vasodilator
Antiviral
corticosteroid
electrolyte

Total Waste
($)

norepinephrine
phenylephrine
Acetaminophen
diltiazem
gentamicin
tobramycin
Meropenem
cefazolin
cefepime
ceftaroline fosamil
ceftriaxone
daptomycin

Total
Waste (# of
bags)
1
12
2
2
6
2
31
20
2
3
1
1

vancomycin
azithromycin
bacitracin
aztreonam
Ampicillin
ampicillin-sulbactam
penicillin G potassium
piperacillin-tazobactam
Levetiracetam
valproate sodium
octroetide
vasopressin
ondansetron
anidulafungin
fluconazole
bumetanide
chlorothiazide
furosemide
nitroprusside
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3
5
5
1
8
25
6
6
1
2
3
1
4
3
1
1
3
1

82.58
11.16
23.4
173.69
1.79
14.76
76.31
13.8
22.96
2.2
24.2
734.88
1.15
168.56
25.29
1.85
48.84
5.82
280.92

Acyclovir
methylprednisolone
succinate
sodium bicarbonate

1
3

17.6
58.22

10

144.72
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175.1
121.1
63.24
21.24
50.58
65.55
186.25
40.22
2.31
434.37
6.33
458.8

Table 3. Total IV Solution Wastage in a 30-Day Period (continued)
Drug Class

Drug Name

electrolyte
electrolyte
electrolyte
electrolyte
electrolyte
insulin
iron salt
NSAID
oxytocic agent
vitamin
vitamin
vitamin

calcium glucanate
potassium chloride
potassium phosphate
sodium chloride
sodium phosphate
Humulin R
sodium ferric gluconate
Ibuprofen
oxytocin
folic acid
MVI infuvite
thiamine
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Total
Waste (# of
bags)
1
40
3
5
4
6
1
18
4
13
12
18

Total Waste
($)
4.02
96.72
38.28
12.6
38.28
2.54
19.66
79.65
11
19.6
92.76
50.76

Table 4. Top 10 Drugs by Number of Bags Wasted
Drug Name
Potassium Chloride
Meropenem
Penicillin G Potassium
Cefazolin
Ibuprofen
Thiamine
Vancomycin
Folic Acid
Phenylephrine
MVI Infuvite

Total Waste (# of bags)
40
31
25
20
18
18
14
13
12
12

potassium chloride
Meropenem
penicillin G potassium
13%
32%

cefazolin
10%

Ibuprofen
thiamine

8%
3%
4%
4%

6%
4% 4% 6%

vancomycin
folic acid
phenylephrine

6%

MVI infuvite
sodium bicarbonate

other

Figure 2. Percentage of Top 10 Drugs in Total Number of Bags Wasted
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Table 5. Top 10 Drug Classes by Number of Bags Wasted
Drug Class
Electrolyte
Vitamin
Antibiotic, Penicillin
Antibiotic, Carbapenem
Antibiotic, Cephalosporin
NSAID
Antibiotic, Glycopeptide
Alpha-Adrenergic Agonist
Antibiotic, Aminoglycoside
Anticonvulsant

Total Waste (# of bags)
63
43
40
31
26
18
14
12
8
7

electrolyte
vitamin
antibiotic, penicillin

17%

20%

2%
2%
4%
4%

antibiotic, carbapenem
antibiotic, cephalosporin
14%

NSAID

antibiotic, glycopeptide

6%
8%
10%

alpha-adrenergic agonist

13%

antibiotic, aminoglycoside
anticonvulsant
other

Figure 3. Percentage of Top 10 Drug Classes in Total Number of Bags Wasted
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Table 6. Top 10 Drugs by Drug Cost
Drug Name
Vasopressin
Daptomycin
Ceftaroline Fosamil
Nitroprusside
Meropenem
Norepinephrine
Aztreonam
Anidulafungin
Sodium Bicarbonate
Phenylephrine

Total Waste ($)
734.88
458.8
434.37
280.92
186.25
175.1
173.69
168.56
144.72
121.1

vasopressin
daptomycin
ceftaroline fosamil
18%

nitroprusside

29%

Meropenem
11%
3%
4%
4%
4%

norepinephrine
aztreonam

11%

4% 5% 7%

anidulafungin
sodium bicarbonate
phenylephrine
other

Figure 4. Percentage of Top 10 Drugs in Total Drug Cost

21

Table 7. Top 10 Drug Classes by Drug Cost
Drug Class
Antidiuretic Hormone Analog
Antibiotic, Cephalosporin
Antibiotic, Cyclic Lipopeptide
Electrolyte
Antihypertensive, Vasodilator
Antifungal
Antibiotic, Carbapenem
Alpha-/Beta- Agonist
Antibiotic, Monobactam
Vitamin

Total Waste ($)
734.88
483.23
458.8
334.62
280.92
193.85
186.25
175.1
173.69
163.12

antidiuretic hormone analog
antibiotic, cephalosporin
antibiotic, cyclic lipopeptide

18%

21%

electrolyte
antihypertensive, vasodilator

4%

12%

4%

antifungal
antibiotic, carbapenem

4%
5%

alpha-/beta- agonist

12%
5%

7%

antibiotic, monobactam

8%

vitamin
other

Figure 5. Percentage of Top 10 Drug Classes in Total Drug Cost
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There were only two drugs that were in both the top 10 drugs wasted by number
of bags and by drug cost: meropenem and phenylephrine. Tables 8 and 9 are summaries
of the daily log. All 31 of the meropenem bags were expired from Omnicell machines.
All 12 of the phenylephrine infusions were expired bags retrieved from the IV room
fridge.
Table 8. Meropenem Daily Log Summary
Dose
500mg
1g
Total

Location
Omnicell
Omnicell

Order Type
Restock
Restock

# of Bags
18
13
31

Drug Cost ($)
76.14
110.11
186.25

Table 9. Phenylephrine Daily Log Summary
Dose
20mg
20mg
20mg
40mg
40mg
Total

Location
Fridge
Fridge
Fridge
Fridge
Fridge

Order Type
Overstock
PRN
FD
Overstock
PRN

# of Bags
5
3
1
2
1
12

Drug Cost ($)
40.4
24.24
8.08
32.32
16.16
121.2

There were 4 drug classes that were represented in the top 10 drug classes wasted
both by number of bags and by drug cost:


electrolytes: sodium bicarbonate, calcium gluconate, potassium chloride,
potassium phosphate, sodium chloride, sodium phosphate



vitamin: folic acid, multivitamin infuvite, thiamine



carbapenem antibiotics: meropenem



cephalosporin antibiotics: cefazolin, cefepime, ceftaroline fosamil, ceftriaxone
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Figure 6 shows how each drug in these 4 drug classes compare in terms of
number of bags wasted and drug cost. The red line and the y-axis on the right represent
the total drug cost of each drug. The cost of each drug is labeled on the graph. The blue
bars and the y-axis on the left represent the number of bags wasted for each drug.

45

500

434.37

40

Total Waste (# of bags)

35

Total Waste ($)

400
350

30

300

25

250

20 186.25

200

144.72

15

96.72

10
5

450

40.22

38.28
2.31

6.33

4.02

150

92.76
12.6

38.28

50.76
19.6

0

100
50
0

Figure 6. Comparison of IV Wastage by Number of Bags Wasted and by Drug Cost
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DISCUSSION
Major Findings
In a 30-day period in March 2017, The BMH-NM (Oxford) pharmacy wasted
over 280 IV solution bags, resulting in over $4000 of financial loss in drug cost alone.
This wastage is significant for a rural hospital pharmacy with a limited budget. The
following discussion will examine the meaning of the findings in relation to the two study
objectives and why the findings are important.

1. Categorizing the IV solution wastage by drug and drug class
The top ten drugs wasted by number of bags represent IV solutions that were
wasted the most often. To examine the possible reasons behind their large wastage, one
needs to understand when and where these solutions are made and stored.
Within these top 10 drugs, 5 drugs are kept in separate overstock bins in the IV
fridge, meaning these bags are made in batches in anticipation of orders. These drugs
include potassium chloride, penicillin G potassium, cefazolin, ibuprofen, and vancomycin.
Because they are prescribed often, making them ahead of time in batches reduces the
workload compared to making them one bag at a time as needed. The disadvantage of
making them in bulk is that sometimes supply exceeds demand, and these bags may
remain unused and expire in the fridge. The expiration time for these drugs vary, from 3
days for potassium chloride to 2 weeks for vancomycin, and one can see how drugs with
shorter expiration time can be wasted at a higher rate.
25

Another disadvantage of making these bags in advance has to do with missing medication.
Nurses frequently contact the pharmacy about missing IV doses, and usually pharmacy
technicians try their best to locate the missing bag before asking the IV technician to
make a replacement bag, since it is frustrating for the IV technician to go through the
trouble of gowning up just to make a single IV bag that he or she has already made earlier
that day. For these "ready-to-go" IV solutions, however, technicians have less incentive
to look for the missing dose, since replacing the missing bag is as easy as opening the
fridge and grabbing another bag out of the bin. The problem with this behavior is that the
missing IV dose is still somewhere in the nursing unit, and it will remain unused and
expire there. For these two reasons, the 5 drugs that are used to make these overstock IV
solutions may be wasted at a higher rate than other drugs.
The other 5 drugs in the top 10 drugs wasted by number of bags include
meropenem, phenylephrine, folic acid, thiamine, and multivitamin infuvite. There will be
two sections later dedicated to meropenem and phenylephrine. As for the other three,
they are frequently used in combination to make what is known as a "banana bag," named
for the yellow color and the high vitamin concentration of the solution. These bags are
infused continuously, so they are made as part of the IV batch that prints at scheduled
times during the day. The solution has a short expiration time of 24 hours, so if a bag gets
returned to the pharmacy after remaining unused in the nursing unit, there is almost never
a chance for the bag to be recycled and given to another patient. During this study, 12
"banana bags" were wasted, leading to its spot in the top 10 list. This finding is not
surprising. Technicians often joke about the futility of making these multivitamin
infusions because sometimes it feels like every "banana bag" they make gets returned and
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wasted at the pharmacy a day later. The study result supports their observation because
these solutions are indeed wasted at a higher rate than most other IV infusions. A possible
strategy to mitigate the waste is to change these orders from scheduled to PRN, so that
these bags are only made as needed.
The top 10 drug classes wasted include 5 different classes of antibiotics,
electrolytes, vitamins, NSAIDs, alpha-adrenergic agonist, and anticonvulsant. The only
NSAID in the results was ibuprofen, the only alpha-adrenergic agonist was phenylephrine,
and the anticonvulsants were levetiracetam and valproic acid. Antibiotics are some of the
most frequently used medication at hospitals, so it is not surprising that they are also
some of the most frequently wasted solutions. These bags may remain unused due to
order changes, patient discharge, or a variety of other factors. Electrolytes, vitamins,
NSAIDs, and alpha-adrenergic agonist all showed up in the top 10 drugs wasted by
number of bags list as well, and possible reasons for their wastage either have already
been discussed or will be discussed (in the case of phenylephrine). Anticonvulsant was a
surprising drug class in the top 10 list, but a quick look at the data shows that only 7 bags
were wasted in this drug class, and since both levetiracetam and valproic acid have short
expiration time of 24 hours, it is understandable that 7 bags could have been wasted in a
month.

2. Quantify the financial loss in terms of drug cost
The top ten drugs wasted by drug cost included 2 types of medications. The top 4
drugs, namely vasopressin, daptomycin, ceftaroline fosamil, and nitroprusside, were in
this list because the unit price for each drug was over $100. Vasopressin, for example,
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costs $122.48 per 2 ml vial. Nitroprusside is even more expensive at $280.92 per 2 ml
vial. Therefore, wasting just one IV bag made from one of these high-cost drugs can have
the same financial impact as wasting dozens of bags made from a cheaper drug. The other
6 drugs in this list (meropenem, norepinephrine, aztreonam, anidulafungin, sodium
bicarbonate, and phenylephrine) are relatively cheaper, with unit prices under $50, but
the sheer volume of bags wasted resulted in costly drug loss. It is important to note that
wastage from these ten drugs constituted 71% of the total financial loss due to drug cost,
so by focusing on strategies to reduce waste in these 10 drugs, the pharmacy can bring
the cost down significantly.
The top ten drug classes wasted by drug cost reflect mostly similar results to the
top ten drugs. 7 of the ten drug classes are represented in the top 10 drugs wasted by drug
cost, and they are hormone analog antidiuretic (vasopressin), cyclic lipopeptide antibiotic
(daptomycin), vasodilator antihypertensive (nitroprusside), antifungal (anidulafungin),
carbapenem antibiotic (meropenem), alpha-/beta-agonist (norepinephrine), and
monobactam antibiotic (aztreonam). The other three drug classes, cephalosporin
antibiotics, electrolytes, and vitamins, were also in the top ten drug classes wasted by
number of bags, so their presence in the top ten by drug cost list may be explained by the
high volume of waste for each drug class.

3. Common drugs and drug classes in top 10 wasted both by number of bags and by
drug cost
There are two drugs that are in the top 10 drugs wasted both by number of bags
and by drug cost: meropenem and phenylephrine. All 31 bags of meropenem that were
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wasted came from Omnicell restocks, meaning that these bags were made in the
pharmacy and put in the Omnicell machines by rounding technicians, but were never
used by nurses prior to their expiration date. These pop-together meropenem preparations
are given an expiration time of 15 days. They are kept in almost every nursing unit, in
either the 500 mg or 1 g strength or both. Depending on the type of patients at each unit,
demand for meropenem fluctuates greatly, so some units might need daily restocks of
meropenem IV bags, while other units have a surplus of them. While the unit price of
meropenem isn't high, 31 bags ended up costing the pharmacy nearly $200 in a month.
Meropenem wastage is not a problem unique to the BMH-NM (Oxford) pharmacy.
Several papers have examined ways to reduce the cost of meropenem acquisition while
maintaining clinical outcomes. In a paper published in the American Journal of HealthSystem Pharmacy, Kotapati (2004) found that a dosing regimen of meropenem at 500 mg
every 6 hours yielded similar clinical outcome to a dosing regimen of 1 g every 8 hours
and reduced the daily drug acquisition cost for meropenem at a large teaching hospital.
Another study by Patel (2007) published in Pharmacotherapy confirmed that the
alternative dosing regimen for meropenem reduced total daily dose and almost halved the
drug cost in a 417-bed privately owned community hospital. So perhaps switching to this
alternative dosing regimen and stocking only 500 mg meropenem in Omnicell machines
can reduce cost. Still, there needs to be more research on whether this change can reduce
wastage.
Phenylephrine infusions are usually PRN or as needed orders, but because of the
frequency of use, some technicians like to make a couple extra bags to keep in the fridge
so they don't have to go back into the IV room every other hour to make this IV solution.
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Phenylephrine IV solutions are only good for 24 hours, so sometimes they expire in the
fridge before being used. Other times, multiple bags are sent up to the nurse at once
because the IV solution is flowing into the patient at a rapid rate continuously, and the
nurse wants to makes sure there is no lag time between the first bag running dry and
hanging of the second bag. Unfortunately not every bag is hung, and the extra bags either
expire in the unit or are brought back to the pharmacy to be wasted. In the 30-day data
collection period, 12 bags of phenylephrine were wasted, resulting in a loss of $121.2.
While these numbers may seem low, this is still a drug that should be prioritized for
reducing wastage because it was in the top 10 list for both wastage criteria.
Finally, there were 4 drug classes that were in the top 10 drug classes wasted both
by number of bags and by drug cost, and Figure 15 showed how number of bags and cost
related for each drug under these four drug classes. It becomes clear that for some drugs
like ceftaroline fosamil, the cost is the driving factor behind its high wastage, whereas
potassium chloride had 10 times more bags wasted than ceftaroline fosamil but only a
quarter of the drug cost loss. The figure attempts to show that in order for the pharmacy
to cut down IV solution wastage, they must consider volume and cost together to reduce
financial loss.

Practical Relevance
The data collection process brought forth a few unexpected insights into the
practical relevance of this study. First, the daily data collection process was simple and
quick, with time ranging from 10 minutes to 20 minutes per day to complete all the tasks,
including entering data, crediting the bags, removing and shredding labels, and cutting
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the bags up in the sink, all (except for data entry) of which are tasks that pharmacy
technicians already do as a part of normal work routine. Therefore, a daily log of wasted
IV solutions can be easily incorporated into the nightshift technician's work flow.
Second, the data collection process eased the workload of the rounding
technicians by cutting out the time they would normally spend on crediting the wasted IV
bag, and it eased the workload of the IV technicians by cutting out the time they would
normally spend on cutting up the bags in the sink. In fact, at the conclusion of the data
collection, several technicians said that they've been "spoiled" and would miss me
coming to the pharmacy every night for data collection.
Third, the data collection process increased awareness of IV solution wastage, and
even medication wastage in general, for both technicians and pharmacists. By the second
week of data collection, the staff began asking me, "how are we doing today (in terms of
number of bags wasted)?" By the third week, a few techs and pharmacists had picked up
on the fact that meropenem was being wasted at a high rate, and one pharmacist remarked
that she was wary of restocking Omnicell machines with meropenem because, "we would
end up expiring them anyway." By the fourth week, which is the week that staff conducts
medication expiration throughout the pharmacy and the Omnicell machines, the lead tech
had asked me if I plan on collecting data on all medication wasted, i.e. pill, insulins, etc.
because of the high volume of drugs being wasted that month. In a matter of 30 days, the
pharmacy staff became more invested in IV solution wastage and more vocal about their
concerns. If this project were continued for a longer period of time, the cultural change
might be even more evident.
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Study Limitations
There are a number of limitations with this study. First, the study was conducted
in a rural hospital in Mississippi that serves a patient population with a distinct regional
disease prevalence high in obesity, Type II diabetes, hypertension, and other
cardiovascular diseases. The data, therefore, has low external validity. The findings of
this study cannot be used to predict or to be compared to IV solution wastage patterns at
larger hospitals in urban areas, or in specialty hospitals that cater to oncology patients or
pediatrics.
Second, the study was conducted in a brief 30-day period in March. March is
usually not the busiest month for hospitals, especially for BMH-NM (Oxford). At this
hospital, peak inpatient census happens when the influenza season and the cold winter
months collide, from October to February. Therefore, the wastage observed in this study
might be an underestimate of the IV solution wastage in the winter months. On the other
hand, March is usually busier than the summer months between June and August, so this
study's findings might be an overestimate for those months. Clearly, the optimal study
duration should be a yearlong study to accurately reflect the average amount of IV
solution wastage per month, but due to constraints on time and resources, this study was
only able to collect data from one month.
Third, the study only quantified one aspect of the financial loss, which is drug
cost. This study did not take into account the cost of fluid bags in which the drugs were
injected, nor the supply cost of making IV solutions (i.e. syringes, needles, sterile garbs,
etc.), nor the labor cost of the pharmacy technicians and pharmacists. Therefore, the
$4000 loss is only a portion of the total financial loss due to IV solution wastage. The
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findings might be more striking if all aspects of financial loss were taken into account,
but due to difficulties in obtaining fluid costs, supply costs, and employee pay rates, as
well as constructing a model for calculating the labor cost per bag, this study only
quantified the drug cost of IV solution wastage. Even the drug cost alone was calculated
conservatively. For example, the drug cost from multidose vials was calculated with the
assumption that each vial was used to make as many IV bags as possible before it was
thrown away. In reality, multidose vials are frequently discarded with some drug still left
in them, so the actual drug cost from multidose vials would be higher than what this
study reflects.
Finally, this study did not investigate the cause of IV wastage. To identify the
cause of waste for each bag, one would need access to each patient's electronic medical
record, which is difficult to obtain as a researcher. One would also need a thorough
understanding of the nursing workflow and physician workflow to fully investigate why
some IV solutions remain unused. Therefore, while the result confirmed that IV wastage
is costing the pharmacy a lot of money, this study cannot provide any definite answers on
strategies to reduce IV wastage.

Further Research
Some ideas for further research include expanding the study period from one
month to a year to investigate the long-term impact of IV solution wastage, identifying
and comparing IV solution wastage in two rural hospitals in Mississippi, and
investigating the cause of IV solution wastage at a hospital pharmacy.
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CONCLUSION
IV solution wastage is costing the BMH-NM (Oxford) pharmacy over $4000 per
month, and identifying this problem is the first step in attempting to mitigate the wastage.
Pharmacy directors can use wastage data to pinpoint areas for improvement and enact
changes that can most effectively reduce IV solution wastage.
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